Ahorra 5 meses con 1 año de Premium al 35% dto ¡Lo quiero!
New Evidence to Improve Management of Patients with or at High Risk of ASCVD Events
  • 10/06/2019
  • 5
  • 0
  • 0

New Evidence to Improve Management of Patients with or at High Risk of ASCVD Events

Audio no disponible. Inténtalo más tarde.
  • Descargar
  • Compartir
  • Me gusta
  • Más
    • Escuchar en popup
    • Denunciar Contenido
Preparando para la descarga

Preparando audio para descarga.

Escucha patrocinada. El audio empezará en pocos segundos...

Escucha sin anuncios y sin esperas con iVoox Premium

Pruébalo Gratis

X

Descripción de New Evidence to Improve Management of Patients with or at High Risk of ASCVD Events

Guest: Michael B. Bottorff, PharmD
Guest: Daniel E. Hilleman, PharmD
This innovative CPE activity features leading international experts addressing the reduction of residual risk in patients with, or at high risk of, atherosclerotic cardiovascular disease (ASCVD) beyond LDL-C lowering. The program is based on a live satellite symposium and will include the following topics:
Omega-3 FAs and their use in patients with ASCVD
Case simulations on personalization of care in ASCVD
Pharmacist implications of new cholesterol guidelines and CVOT outcomes trials such as REDUCE-IT

For more information, contact Medtelligence at info@medtelligence.net.
Media: Internet

Mostrar Ocultar

Clinical Pharmacology CMECE rmd reachMD

Comentarios

Por decisión del propietario, no se aceptan comentarios anónimos. Registrate para comentarlo.

Más de Ciencia y naturaleza

VER TODOS